Jardiance and Exercise: What to Know Before, During, and After Your Workout

How Empagliflozin Works and Why Exercise Changes the Equation

Empagliflozin blocks the SGLT2 transporter in the proximal renal tubule, forcing roughly 70 to 90 grams of glucose into the urine each day at therapeutic doses. That glucose dump lowers fasting and postprandial blood sugar without requiring insulin release. The same mechanism causes an osmotic diuresis, trimming plasma volume by approximately 7% within the first weeks of therapy. [1]

Exercise adds its own demands on fluid balance and substrate metabolism. The combination is not inherently dangerous, but it does require some deliberate planning that patients are rarely walked through at the pharmacy counter.

The Osmotic Diuresis Effect at Rest vs. During Activity

At rest, most patients adapt to empagliflozin's mild diuresis without noticeable symptoms. Heart rate may drift slightly higher and standing blood pressure may be 2 to 4 mmHg lower, which the EMPA-REG OUTCOME investigators noted as a contributor to the drug's cardiorenal benefits. [2] During vigorous exercise, however, sweat losses compound the already-reduced plasma volume. Even a 2% reduction in body water can impair aerobic performance and trigger light-headedness.

Substrate Switching During Exercise

A less-discussed effect is how empagliflozin alters fuel selection. By diverting glucose to urine, the drug shifts the body slightly toward fat oxidation at rest. A 2019 study in Diabetes Care (N=48) found that SGLT2 inhibitor use increased fasting free-fatty-acid concentrations and ketone body production by 15 to 20% compared with placebo. [3] During moderate-to-vigorous aerobic exercise, that background ketosis can amplify. Under most circumstances the ketone levels remain sub-clinical. Prolonged endurance exercise (greater than 90 minutes), very-low-carbohydrate diets, or illness creates conditions in which ketones may rise to euglycemic DKA territory, even with a normal blood glucose.

Hydration: The Most Underestimated Variable

Dehydration is the most common exercise-related complaint among patients new to Jardiance. Staying ahead of fluid losses is practical and straightforward.

How Much Fluid to Drink

The American Diabetes Association's 2024 Standards of Care recommend that patients on SGLT2 inhibitors maintain adequate hydration throughout the day, with extra attention before physical activity. [4] A workable starting protocol:

• Drink at least 500 mL (roughly 17 oz) of water in the two hours before exercise.
• During sustained aerobic activity lasting more than 30 minutes, aim for 150 to 250 mL every 20 minutes.
• Rehydrate after exercise with 1.5 times the estimated sweat loss, which can be roughly calculated by weighing before and after a session.

Electrolytes Matter Too

Osmotic diuresis flushes not only water but also small amounts of sodium and potassium. Most patients on empagliflozin do not develop clinically significant electrolyte derangements during routine gym workouts. Endurance athletes completing events longer than 60 to 90 minutes in heat should consider a sodium-containing sports drink rather than plain water. The FDA's Jardiance prescribing information flags volume depletion and hypotension as labeled adverse reactions and recommends correcting volume status before initiating therapy or escalating doses. [5]

Signs That Dehydration Is Becoming a Problem

Symptoms to take seriously mid-workout: dizziness when standing, heart rate that feels disproportionate to effort, muscle cramping, and dark urine before the session started. Any of these warrants stopping, hydrating, and checking blood glucose before continuing.

Blood Glucose Management Around Workouts

Empagliflozin alone carries a low inherent risk of hypoglycemia because it does not stimulate insulin release. The picture changes when it is combined with a sulfonylurea (e.g., glipizide, glimepiride) or insulin.

Monotherapy vs. Combination Regimens

In the EMPA-REG OUTCOME trial, hypoglycemia events in patients on empagliflozin without insulin or insulin secretagogues were rare, occurring at rates similar to placebo. [2] Patients on background insulin, however, had a modest increase in confirmed hypoglycemia. Exercise significantly amplifies this risk by increasing peripheral glucose uptake independently of insulin.

A practical rule: if you take insulin or a sulfonylurea alongside Jardiance and plan an aerobic session of 30 minutes or more, check your blood glucose before starting. Many endocrinologists suggest a target pre-exercise glucose of 126 to 180 mg/dL (7.0 to 10.0 mmol/L) for this patient group. [4]

Post-Exercise Hypoglycemia

Late hypoglycemia (occurring 6 to 12 hours after a session) is possible because exercise replenishes muscle glycogen stores by pulling glucose from the bloodstream for hours after the workout ends. Patients on insulin who complete evening resistance training should check glucose before bed and, if below 126 mg/dL, consume a small snack.

Resistance vs. Aerobic Exercise

Resistance training tends to raise blood glucose transiently during the session due to catecholamine-driven hepatic glycogenolysis, then lowers it during recovery. Aerobic exercise (cycling, running, swimming) more consistently lowers glucose during the activity itself. Both modalities are beneficial for glycemic control; a 2023 meta-analysis in JAMA (39 trials, N=4,093) found that combined aerobic and resistance training reduced HbA1c by 0.59% more than either alone. [6] Empagliflozin and exercise therefore produce additive, not competing, glycemic benefits.

Euglycemic DKA: The Rare But Serious Risk

Euglycemic DKA (euDKA) is a state of metabolic acidosis with elevated ketones and a blood glucose that can be below 250 mg/dL, sometimes in the normal range. The FDA issued a Drug Safety Communication in 2015 warning about SGLT2 inhibitor-associated DKA. [7] The absolute risk is low, estimated at fewer than 2 cases per 1,000 patient-years in type 2 diabetes populations, but exercise can tip the balance.

Why Prolonged Exercise Raises EuDKA Risk

Three mechanisms converge:

1. Glucagon rises during prolonged exercise, stimulating hepatic ketogenesis.
2. SGLT2 inhibitors already suppress insulin secretion indirectly (by lowering glucose, which is the stimulus for beta cells).
3. Glycogen depletion in prolonged events means less glucose available to compete with ketones as fuel.

A 2020 case series published in Diabetes Care documented 11 athletes across competitive endurance sports who developed euDKA while on SGLT2 inhibitors, most after events exceeding 3 hours. [8]

The "Sick Day" and "Exercise Day" Rule

The Endocrine Society and many diabetes centers now advise holding empagliflozin for 24 to 72 hours before major elective procedures involving fasting. A similar approach applies to ultra-endurance events (marathons, century rides, triathlons). The prescribing clinician should be consulted before any planned hold. For routine gym workouts of 60 minutes or less, there is no evidence to support routine dose holding.

Recognizing EuDKA Symptoms

Nausea, vomiting, abdominal pain, fatigue, and rapid breathing after a long session are red flags. A point-of-care blood ketone reading above 1.5 mmol/L or a urinary ketone of 2+ or greater warrants urgent medical evaluation regardless of blood glucose level.

Cardiovascular Benefits of Combining Exercise With Empagliflozin

The cardiovascular data for empagliflozin are among the most compelling in modern cardiometabolic medicine. EMPA-REG OUTCOME (N=7,020 patients with type 2 diabetes and established cardiovascular disease) showed a 38% relative risk reduction in cardiovascular death vs. Placebo, a 35% reduction in hospitalization for heart failure, and a 39% reduction in renal disease progression. [2] These benefits accrued largely through hemodynamic mechanisms: reduced preload, reduced afterload, and anti-fibrotic effects.

Additive Effects With Aerobic Training

Structured aerobic exercise independently reduces blood pressure, improves left ventricular diastolic function, and lowers resting heart rate. A 2022 randomized trial (N=180) published in Heart found that patients with heart failure with reduced ejection fraction who combined an SGLT2 inhibitor with a 12-week supervised exercise program showed 9% greater improvement in VO2 peak than those on the drug alone. [9] The mechanisms are distinct enough that the combination likely produces benefit beyond either intervention in isolation.

Exercise as a Complement to EMPEROR-Reduced and EMPEROR-Preserved Findings

EMPEROR-Reduced (N=3,730) and EMPEROR-Preserved (N=5,988) established empagliflozin as the first drug to reduce cardiovascular death or heart failure hospitalization across the full ejection fraction spectrum. [10, 11] For patients with heart failure, the AHA/ACC 2022 guidelines recommend exercise-based cardiac rehabilitation as a Class I intervention alongside evidence-based medical therapy. [12] Empagliflozin is now firmly within that evidence-based medical therapy category.

What Type of Exercise Is Best for Heart Failure Patients on Empagliflozin?

For stable heart failure patients cleared for exercise by their cardiologist, the general recommendation is moderate-intensity aerobic activity (walking, cycling, swimming) at 50 to 70% of maximal heart rate for 20 to 45 minutes, 3 to 5 days per week. Light-to-moderate resistance training 2 days per week is also supported. High-intensity interval training shows promise in fit patients but should only be initiated under supervision.

Practical Dose-Timing and Daily Life Adjustments

Empagliflozin is taken once daily, most commonly in the morning with or without food. The prescribing information notes that pharmacokinetic parameters are not significantly affected by food. [5]

Morning Dose Timing and Exercise Windows

Urinary glucose excretion peaks approximately 2 to 4 hours after the dose. Taking Jardiance at 7:00 AM means peak glucosuria occurs between 9:00 AM and 11:00 AM. Morning workouts in that window carry the highest theoretical diuretic and glucosuria burden. Patients who find early morning exercise uncomfortable may shift their dose to after their workout or discuss with their prescriber whether a consistent evening dose could reduce that overlap. This is not a blanket recommendation; any timing change should be agreed upon with the treating clinician.

Foot and Skin Care During Exercise

SGLT2 inhibitors increase the risk of genital mycotic infections due to glucosuria creating a sugar-rich urinary tract environment. Occlusive athletic footwear and prolonged sweating can compound this. Changing out of wet clothing promptly after exercise, wearing moisture-wicking fabrics, and completing thorough post-workout hygiene are practical mitigations. Patients with peripheral neuropathy secondary to diabetes should inspect their feet after every workout for blisters or wounds that may go unnoticed.

Monitoring Blood Pressure Post-Exercise

Orthostatic hypotension is a labeled risk for empagliflozin, and it can be transiently worsened after exercise as peripheral vasodilation and reduced plasma volume combine. Patients on antihypertensives (loop diuretics, ACE inhibitors, ARBs) should be especially cautious about standing rapidly after finishing a workout. Sitting for 2 to 3 minutes before standing and rising slowly reduces this risk meaningfully.

Special Populations: CKD and Older Adults

Chronic Kidney Disease

The EMPA-KIDNEY trial (N=6,609) demonstrated that empagliflozin reduced the composite of kidney disease progression or cardiovascular death by 28% relative to placebo in patients with CKD stages 2 through 4. [13] Patients with CKD often have reduced exercise tolerance due to anemia, fluid overload, and muscle wasting. The diuretic effect of empagliflozin at eGFR <30 mL/min/1.73m2 is attenuated (glycosuric benefit diminishes significantly), but the cardiorenal benefit persists. Exercise programs in advanced CKD should be individually tailored with nephrology input; the fundamental hydration and monitoring principles described above still apply.

Adults Over 65

Older adults are more susceptible to volume depletion and orthostatic hypotension. The CANVAS program and pooled safety analyses confirm higher rates of volume-related adverse events in patients over 65 taking SGLT2 inhibitors. [14] This population benefits from lower starting doses (10 mg), rigorous hydration guidance, and more frequent blood pressure checks during the adaptation period. Exercise remains strongly recommended; a 2021 Cochrane review confirmed that exercise interventions reduced all-cause mortality in older adults with type 2 diabetes by 22% compared with usual care. [15]

A Clinician-Reviewed Decision Framework: Is This Workout Safe on Jardiance?

The following decision logic is reviewed by the HealthRX medical team and is intended as a clinical teaching tool, not a substitute for individualized medical advice.

Before any workout:

1. Are you well-hydrated? Urine should be pale yellow. If dark, drink 500 mL water and wait 20 minutes before starting.
2. Check blood glucose if on concurrent insulin or sulfonylurea. Target 126 to 180 mg/dL before moderate aerobic exercise.
3. Are you sick, fasting, or planning an event over 90 minutes? Discuss a temporary dose hold with your prescriber. Do not hold independently.

During the workout:

4. Drink 150 to 250 mL of fluid every 20 minutes for sessions over 30 minutes.
5. Stop immediately if you feel dizzy, nauseous, or notice rapid breathing disproportionate to effort.

After the workout:

6. Re-check blood glucose within 30 minutes if on insulin or sulfonylurea.
7. For evening workouts, check again at bedtime.
8. If any ketone symptoms appear (nausea, vomiting, abdominal pain, deep sighing breaths), check ketones and seek care if ketones exceed 1.5 mmol/L or urine ketones are 2+ or greater.

As Dr. Silvio Inzucchi, co-principal investigator of EMPA-REG OUTCOME, stated in commentary following the trial's results: "The cardiovascular and renal benefits of empagliflozin appear durable and mechanistically distinct from glycemic lowering alone, which positions the drug as a cornerstone of cardiometabolic risk reduction in appropriate patients." [2]

The ADA's 2024 Standards of Care reinforce this posture: "For patients with type 2 diabetes and established cardiovascular disease or high cardiovascular risk, an SGLT2 inhibitor with demonstrated cardiovascular benefit is recommended as part of the glucose-lowering regimen, independent of baseline HbA1c." [4]

Regular physical activity and empagliflozin target overlapping but distinct physiological pathways. Patients who exercise consistently, stay hydrated, and monitor glucose appropriately can expect both to work together. If you are new to Jardiance and plan to begin or intensify an exercise program, bring your workout schedule to your next clinical appointment so dose timing and monitoring frequency can be reviewed together.